Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis
Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): S.M. Jinnaah, L. Owens, C. Cabalag, M.M. Lee, D.S. Liu
Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826001019?dgcid=rss_sd_all
Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826001019?dgcid=rss_sd_all
“Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis.” ESMO Gastrointestinal Oncology.
@article{article44824,
title = {Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826001019?dgcid=rss_sd_all}
}